Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 57
Filter
1.
Rev. peru. med. exp. salud publica ; 39(3): 372-375, jul.-sep. 2022. tab
Article in Spanish | LILACS | ID: biblio-1410013

ABSTRACT

RESUMEN Saprochaete capitata es una causa rara de infección fúngica invasiva en pacientes inmunocomprometidos con alta mortalidad y resistencia antifúngica. Presentamos el caso de un niño de cinco años con diagnóstico de aplasia medular, sometido a trasplante de progenitores hematopoyéticos (TPH), que cursó con neutropenia febril persistente, dolor abdominal intenso, aparición de lesiones maculopapulares en piel y deterioro de la función renal. Se identificó la presencia de S. capitata, en hemocultivos transcatéter venoso central. Esta infección fúngica invasiva resulta ser rara, pero emergente y potencialmente mortal, en pacientes con neutropenia febril persistente y uso prolongado de dispositivos invasivos intravasculares como catéter venoso central.


ABSTRACT Saprochaete capitata is a rare cause of invasive fungal infection in immunocompromised patients with high mortality and antifungal resistance. We present the case of a 5-year-old boy with bone marrow aplasia, who underwent hematopoietic stem cell transplantation (HSCT) and presented persistent febrile neutropenia, abdominal pain, appearance of maculopapular lesions on the skin, and impaired renal function. The presence of S. capitata was identified by blood culture from a central venous catheter. This invasive fungal infection is rare but emergent and life-threatening, especially in immunocompromised patients with persistent febrile neutropenia and prolonged use of invasive devices such as central venous catheters.


Subject(s)
Humans , Male , Child, Preschool , Immunocompromised Host , Invasive Fungal Infections/microbiology , Geotrichosis/microbiology , Geotrichum/isolation & purification , Anemia, Aplastic/complications , Fatal Outcome , Invasive Fungal Infections/drug therapy , Geotrichosis/drug therapy , Antifungal Agents/therapeutic use
4.
J Mycol Med ; 28(2): 387-389, 2018 Jun.
Article in French | MEDLINE | ID: mdl-29709266

ABSTRACT

We are reporting the case of an 82-year-old Yemeni patient, renal transplant recipient who was admitted to our institution and who subsequently developed disseminated infection with Saprochaete capitata. This pathogenic fungus is rarely reported in patients with solid organ trans-plants. Saprochaete capitata is an emerging fungal pathogen, ubiquitously spread in the environment. This is the second case to our knowledge of infection with Saprochaete capitata in a renal transplant patient. Our patient was treated for multiple nosocomial infections with prolonged antibiotic courses. He succumbed to the infection with Saprochaete capitate after several weeks spent in the intensive care unit.


Subject(s)
Cross Infection/microbiology , Geotrichosis/microbiology , Geotrichum/isolation & purification , Kidney Transplantation/adverse effects , Aged, 80 and over , Antifungal Agents/therapeutic use , Cross Infection/drug therapy , Echinocandins/therapeutic use , Fatal Outcome , Fungemia/drug therapy , Fungemia/microbiology , Geotrichosis/blood , Geotrichosis/drug therapy , Geotrichum/pathogenicity , Humans , Intensive Care Units , Male , Transplant Recipients
5.
Article in English | MEDLINE | ID: mdl-29229638

ABSTRACT

Saprochaete capitata, formerly known as Geotrichum capitatum, is an emerging fungal pathogen with low susceptibility to echinocandins. Here, we report the nucleotide sequence of the S. capitata hot spot 1 region of the FKS gene (FKS HS1), which codifies for the catalytic subunit of ß-1,3-d-glucan synthase, the target of echinocandins. For that purpose, we first designed degenerated oligonucleotide primers derived from conserved flanking regions of the FKS1 HS1 segment of 12 different fungal species. Interestingly, analysis of the translated FKS HS1 sequences of 12 isolates of S. capitata revealed that all of them exhibited the same F-to-L substitution in a position that is highly related to reduced echinocandin susceptibility.


Subject(s)
Antifungal Agents/pharmacology , Drug Resistance, Fungal/genetics , Echinocandins/pharmacology , Fungal Proteins/genetics , Gene Expression Regulation, Fungal , Geotrichum/genetics , Glucosyltransferases/genetics , Amino Acid Substitution , Base Sequence , DNA, Fungal/genetics , Fungal Proteins/metabolism , Geotrichosis/drug therapy , Geotrichosis/microbiology , Geotrichosis/pathology , Geotrichum/drug effects , Geotrichum/growth & development , Geotrichum/isolation & purification , Glucosyltransferases/metabolism , Humans , Microbial Sensitivity Tests , Protein Subunits/genetics , Protein Subunits/metabolism , Sequence Analysis, DNA
6.
Mycoses ; 60(4): 273-279, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28150341

ABSTRACT

Saprochaete and Geotrichum spp. are rare emerging fungi causing invasive fungal diseases in immunosuppressed patients and scarce evidence is available for treatment decisions. Among 505 cases of rare IFD from the FungiScope™ registry, we identified 23 cases of invasive infections caused by these fungi reported from 10 countries over a 12-year period. All cases were adults and previous chemotherapy with associated neutropenia was the most common co-morbidity. Fungaemia was confirmed in 14 (61%) cases and deep organ involvement included lungs, liver, spleen, central nervous system and kidneys. Fungi were S. capitata (n=14), S. clavata (n=5), G. candidum (n=2) and Geotrichum spp. (n=2). Susceptibility was tested in 16 (70%) isolates. All S. capitata and S. clavata isolates with the exception of one S. capitata (MIC 4 mg/L) isolate had MICs>32 mg/L for caspofungin. For micafungin and anidulafungin, MICs varied between 0.25 and >32 mg/L. One case was diagnosed postmortem, 22 patients received targeted treatment, with voriconazole as the most frequent first line drug. Overall mortality was 65% (n=15). Initial echinocandin treatment was associated with worse outcome at day 30 when compared to treatment with other antifungals (amphotericin B ± flucytosine, voriconazole, fluconazole and itraconazole) (P=.036). Echinocandins are not an option for these infections.


Subject(s)
Geotrichosis/microbiology , Geotrichum/isolation & purification , Invasive Fungal Infections/microbiology , Registries , Saccharomycetales/isolation & purification , Adolescent , Adult , Aged , Amphotericin B/pharmacology , Amphotericin B/therapeutic use , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Echinocandins/pharmacology , Echinocandins/therapeutic use , Female , Fluconazole/pharmacology , Fluconazole/therapeutic use , Fungemia/diagnosis , Fungemia/drug therapy , Fungemia/microbiology , Geotrichosis/drug therapy , Geotrichosis/mortality , Geotrichum/classification , Geotrichum/drug effects , Geotrichum/genetics , Humans , Immunocompromised Host , Invasive Fungal Infections/drug therapy , Invasive Fungal Infections/mortality , Lipopeptides/pharmacology , Lipopeptides/therapeutic use , Male , Micafungin , Microbial Sensitivity Tests , Middle Aged , Neutropenia/complications , Neutropenia/drug therapy , Neutropenia/microbiology , Saccharomycetales/classification , Saccharomycetales/drug effects , Saccharomycetales/genetics , Voriconazole/pharmacology , Voriconazole/therapeutic use , Young Adult
8.
New Microbiol ; 39(4): 307-309, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27284991

ABSTRACT

Magnusiomyces capitatus may cause uncommon yet severe infections, especially in patients with haematologic disorders. Diagnosis may be difficult and time-consuming and newer approaches are required including the MALDI-TOF technique implemented with the detection of fungal antigens in the body fluids. The recommended treatment includes amphotericin B alone or in combination with flucytosine. We describe a case of a non-neutropenic patient with M. capitatus pleural infection, as identified by MALDI-TOF, positivity for galactomannan antigen in the BAL fluid, and successfully treated with oral posaconazole in single therapy.


Subject(s)
Antifungal Agents/therapeutic use , Geotrichosis/drug therapy , Geotrichosis/microbiology , Geotrichum , Triazoles/therapeutic use , Aged , Female , Humans
9.
Mycoses ; 59(9): 594-601, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27061932

ABSTRACT

Invasive fungal infections, usually Aspergillus and Candida, represent a major cause of morbidity and mortality in patients with malignant haematological diseases, but in the last years rare fungal infections have more frequently been reported. Here, we report the clinical history of three patients affected with haematological malignancies who developed an infection caused by Geotrichum (G.) clavatum. Two out of three patients were affected by acute myeloid leukaemia (AML), and one by mantle cell lymphoma (MCL). All patients received cytarabine-based chemotherapeutic regimens and developed G. clavatum infection within 3 weeks from therapy initiation. In all cases, G. clavatum was isolated from central venous catheter and peripheral blood cultures. In vitro susceptibility test confirmed an intrinsic resistance to echinocandins and, in all cases, visceral localisations (spleen, liver and lung) were documented by total body computed tomography (CT) scan. A prolonged antifungal therapy with high doses liposomal amphotericin-B was necessary to obtain fever resolution. Only the patient with MCL died while the other two AML recovered, and one of them after received an allogeneic stem cell transplantation. We consecutively reviewed all published cases of infection caused by G. clavatum. Our experience and literature review indicate that G. clavatum can cause invasive infection in haematological patients, mainly in those with acute leukaemia.


Subject(s)
Geotrichosis/complications , Hematologic Neoplasms/complications , Invasive Fungal Infections/complications , Adult , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Central Venous Catheters/microbiology , Drug Resistance, Fungal , Echinocandins/therapeutic use , Fatal Outcome , Female , Geotrichosis/blood , Geotrichosis/epidemiology , Geotrichosis/microbiology , Geotrichum/drug effects , Hematologic Neoplasms/epidemiology , Hematopoietic Stem Cell Transplantation , Humans , Invasive Fungal Infections/diagnostic imaging , Invasive Fungal Infections/epidemiology , Invasive Fungal Infections/microbiology , Italy , Leukemia, Myeloid, Acute/complications , Leukemia, Myeloid, Acute/drug therapy , Leukemia, Myeloid, Acute/microbiology , Liver/diagnostic imaging , Liver/microbiology , Lung/diagnostic imaging , Lung/microbiology , Lymphoma, Mantle-Cell/complications , Lymphoma, Mantle-Cell/drug therapy , Lymphoma, Mantle-Cell/microbiology , Male , Microbial Sensitivity Tests , Middle Aged , Spleen/diagnostic imaging , Spleen/microbiology , Tomography, X-Ray Computed , Young Adult
11.
Braz. j. infect. dis ; 19(5): 549-552, tab
Article in English | LILACS | ID: lil-764502

ABSTRACT

ABSTRACTEmpirical antifungal therapy is most often given to patients with leukemia. However breakthrough fungal infections under antifungal therapy are not uncommon. Four children, with hematologic malignant disease developed mycotic breakthrough infections while on empirical caspofungin treatment for a median of 14 (range 11-19) days. Trichosporon asahii was detected in the blood culture of two patients and Geotrichum capitatum in the other two (one patient also had positive cerebrospinal fluid culture). Because the patients' clinical situation worsened, voriconazole was empirically added for two patients three and five days before the agent was detected. The first sterile blood culture was obtained 3-7 days of voriconazole treatment. All patients reached clear cultures but one patient died. One patient with central nervous system infection with G. capitatum had severe neurological sequelae. Very severe fungal infections can occur during empirical caspofungin therapy. Therefore, patients should be followed closely.


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Male , Antifungal Agents/therapeutic use , Echinocandins/therapeutic use , Febrile Neutropenia/drug therapy , Geotrichosis/diagnosis , Mycoses/diagnosis , Trichosporonosis/diagnosis , Febrile Neutropenia/microbiology , Geotrichosis/microbiology , Mycoses/microbiology , Rare Diseases , Severity of Illness Index , Trichosporonosis/microbiology
12.
Braz J Infect Dis ; 19(5): 549-52, 2015.
Article in English | MEDLINE | ID: mdl-26275731

ABSTRACT

Empirical antifungal therapy is most often given to patients with leukemia. However breakthrough fungal infections under antifungal therapy are not uncommon. Four children, with hematologic malignant disease developed mycotic breakthrough infections while on empirical caspofungin treatment for a median of 14 (range 11-19) days. Trichosporon asahii was detected in the blood culture of two patients and Geotrichum capitatum in the other two (one patient also had positive cerebrospinal fluid culture). Because the patients' clinical situation worsened, voriconazole was empirically added for two patients three and five days before the agent was detected. The first sterile blood culture was obtained 3-7 days of voriconazole treatment. All patients reached clear cultures but one patient died. One patient with central nervous system infection with G. capitatum had severe neurological sequelae. Very severe fungal infections can occur during empirical caspofungin therapy. Therefore, patients should be followed closely.


Subject(s)
Antifungal Agents/therapeutic use , Echinocandins/therapeutic use , Febrile Neutropenia/drug therapy , Geotrichosis/diagnosis , Mycoses/diagnosis , Trichosporonosis/diagnosis , Adolescent , Caspofungin , Child , Child, Preschool , Febrile Neutropenia/microbiology , Female , Geotrichosis/microbiology , Humans , Lipopeptides , Male , Mycoses/microbiology , Rare Diseases , Severity of Illness Index , Trichosporonosis/microbiology
13.
J Mycol Med ; 24(4): 341-4, 2014 Dec.
Article in French | MEDLINE | ID: mdl-25458367

ABSTRACT

Pulmonary geotrichosis is a rare mycosis caused by an arthrospore filamentous fungi of the genus Geotrichum. It is an opportunistic infection that develops when underlying conditions are present, particularly immunosuppression including neutropenia. Pulmonary mycoses in non-neutropenic patients affect two main populations: the solid organ transplanted patients and patients whose local pulmonary defenses are altered by a chronic underlying lung pathology. We report a case of pulmonary infection Geotrichum capitatum in an old tuberculosis patient.


Subject(s)
Geotrichosis/diagnosis , Geotrichum/isolation & purification , Lung Diseases, Fungal/diagnosis , Geotrichosis/microbiology , Geotrichum/pathogenicity , Humans , Immunocompromised Host , Lung Diseases, Fungal/microbiology , Male , Middle Aged , Opportunistic Infections/diagnosis , Opportunistic Infections/microbiology , Tuberculosis, Pulmonary/complications , Tuberculosis, Pulmonary/microbiology
14.
Mycopathologia ; 177(5-6): 319-24, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24748454

ABSTRACT

Invasive Geotrichum clavatum fungal infections are extremely rare and unusual, occurring nearly exclusively in patients experiencing prolonged neutropenia during the treatment for acute myeloid leukaemia. Several groups of cases of fatal G. clavatum infection were reported in France between 2011 and 2012, but the ecological niche has not yet been identified. We report a case of a 32-year-old patient with acute myeloid leukaemia who developed G. clavatum sepsis with primary peritonitis, hepatic nodular lesions, and multivisceral failure during aplasia after induction followed by salvage chemotherapy. He was treated with voriconazole and is still alive 1 year after with controlled disease. We then discuss the epidemiological, clinical, and therapeutic features of these serious fungal infections compared to the published data.


Subject(s)
Geotrichosis/etiology , Geotrichum/isolation & purification , Leukemia, Myeloid, Acute/complications , Adult , Antifungal Agents/therapeutic use , Geotrichosis/drug therapy , Geotrichosis/microbiology , Geotrichum/genetics , Geotrichum/physiology , Humans , Male , Voriconazole/therapeutic use
16.
J Vet Diagn Invest ; 25(6): 795-7, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24153033

ABSTRACT

Geotrichum spp. are ubiquitous, saprotrophic fungi found in soil, organic matter, and silage, as a contaminant in food products and in the digestive tracts of mammals. The current study reports a case of Geotrichum candidum infection with dermatitis in an aborted bovine fetus with skin and lung lesions. A 6-month-old aborted male Holstein Friesian fetus displayed unusual lesions on the skin of the abdomen, thorax, and head, which was excessively thickened and wrinkled. These changes corresponded to orthokeratotic hyperkeratosis, neutrophil accumulation in the stratum corneum, a pyogranulomatous inflammatory infiltrate, and superficial dermal necrosis. Moderate suppurative multifocal pneumonia was observed. Large numbers of mononuclear cells and occasional fibrin thrombi within blood vessels were found in the lungs, brain, and cerebellum. Gridley staining revealed fungal structures within the skin lesions. The mycological exam demonstrated the growth of G. candidum, and phase contrast microscopy conducted on the abomasal fluid revealed hyphae compatible with this agent. The skin lesions observed, in association with the fungus isolated, indicated that the abortion was due to G. candidum infection of the bovine fetus.


Subject(s)
Aborted Fetus , Abortion, Veterinary/microbiology , Cattle Diseases/microbiology , Geotrichosis/veterinary , Geotrichum/growth & development , Skin Diseases/veterinary , Animals , Brazil , Cattle , Fatal Outcome , Female , Geotrichosis/microbiology , Geotrichum/ultrastructure , Histocytochemistry/veterinary , Male , Microscopy, Phase-Contrast/veterinary , Pregnancy , Skin Diseases/microbiology
19.
Turk J Pediatr ; 54(6): 674-8, 2012.
Article in English | MEDLINE | ID: mdl-23692800

ABSTRACT

Geotrichum capitatum, formerly known as Trichosporon capitatum, is an uncommon but frequently fatal invasive fungal infection in immunocompromised patients, especially in hematological malignancies. We report a seven-year-old patient with acute myeloid leukemia with Geotrichum septicemia with involvement of the lungs, liver, spleen, and kidneys, who had a favorable outcome after therapy. Alteration of antifungal treatment to liposomal amphotericin B resolved the fever with favorable clinical response.


Subject(s)
Geotrichosis/microbiology , Geotrichum/isolation & purification , Immunocompromised Host , Leukemia, Myeloid, Acute/immunology , Mannans/immunology , Sepsis/microbiology , Child , Galactose/analogs & derivatives , Geotrichosis/complications , Geotrichosis/immunology , Humans , Leukemia, Myeloid, Acute/complications , Male , Sepsis/complications , Sepsis/immunology
20.
J Mycol Med ; 22(2): 192-6, 2012 Jun.
Article in French | MEDLINE | ID: mdl-23518024

ABSTRACT

UNLABELLED: Fungemia is classically caused by a single species and the detection of more than one species in blood samples is uncommon. We report four cases of mixed fungemia (MF) diagnosed in the parasitology-mycology laboratory of Farhat-Hached hospital in Sousse, Tunisia. The MF episodes occurred in two neonates and two adults suffering from acute myeloid leukemia. Two fungal species were detected concomitantly within the same blood culture in all cases. Species combination was detected by the subculture of the blood culture on Candida ID(®) chromogenic medium in three cases and on Sabouraud agar in one case. Predisposing factors were: indwelling catheters (4/4), broad-spectrum antibiotics (3/4), neutropenia (2/4), exclusive parenteral nutrition (2/4) and Candida colonization (1/4). Patients presented febrile sepsis with no response to broad-spectrum antibiotic therapy in all cases. Outcome under antifungal treatment was favorable in two cases and the two other patients died. CONCLUSION: MF appears similar to the more common monomicrobial fungemia. The use of chromogenic media in routine can improve the detection of MF episodes allowing appropriate antifungal therapy.


Subject(s)
Candida/isolation & purification , Fungemia/microbiology , Geotrichosis/microbiology , Geotrichum/isolation & purification , Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Candida albicans/isolation & purification , Candida tropicalis/isolation & purification , Candidemia/diagnosis , Candidemia/drug therapy , Candidemia/etiology , Candidemia/microbiology , Catheter-Related Infections/diagnosis , Catheter-Related Infections/drug therapy , Catheter-Related Infections/etiology , Catheter-Related Infections/microbiology , Cleft Lip/complications , Cleft Palate/complications , Coinfection , Cross Infection/diagnosis , Cross Infection/drug therapy , Cross Infection/etiology , Cross Infection/microbiology , Culture Media , Epidermolysis Bullosa/complications , Fungemia/diagnosis , Fungemia/drug therapy , Fungemia/etiology , Geotrichosis/diagnosis , Geotrichosis/drug therapy , Geotrichosis/etiology , Humans , Immunocompromised Host , Infant, Newborn , Leukemia, Myeloid, Acute/complications , Leukemia, Myeloid, Acute/drug therapy , Male , Middle Aged , Neutropenia/chemically induced , Neutropenia/complications , Parenteral Nutrition/adverse effects , Tunisia , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...